Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.

Try Elite for Free

A

AKTX

Akari Therapeutics Plc ADR

9.16

Sep 18 • 3:59 PM ET -0.72 (-7.24%)

9.20

Aftermarket • 5:02 PM ET +0.04 (0.44%)

Healthcare Biotechnology USA Nano NASD

Peers: IKT NBP NERV NVCT ALXO BCYC CGEN FATE FHTX CDXS

Scroll to Statements

Index	-
Market Cap	16.03M
Enterprise Value	8.97M
Income	-30.90M
Sales	0.00M
Book/sh	10.62
Cash/sh	4.43
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	6
IPO	May 07, 2013

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	0.86
P/C	2.07
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	0.60
Current Ratio	0.60
Debt/Eq	0.04
LT Debt/Eq	0.00
Option/Short	Yes / Yes

EPS (ttm)	-17.25
EPS next Y	-5.49
EPS next Q	-2.23
EPS this Y	52.32%
EPS next Y	44.32%
EPS next 5Y	46.65%
EPS past 3/5Y	- -
Sales past 3/5Y	- -
EPS Y/Y TTM	-
Sales Y/Y TTM	-
EPS Q/Q	1.39%
Sales Q/Q	-
Earnings	Aug 13 AMC
EPS/Sales Surpr.	100.00% -

Insider Own	0.40%
Insider Trans	0.00%
Inst Own	8.61%
Inst Trans	253.05%
ROA	-69.02%
ROE	-139.80%
ROIC	-166.16%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	-8.13%
SMA50	-2.40%
SMA200	-4.07%
Trades

Shs Outstand	1.75M
Shs Float	1.74M
Short Float	1.73%
Short Ratio	0.40
Short Interest	0.03M
52W High	49.60 -81.53%
52W Low	3.02 203.81%
Volatility	11.10% 12.43%
ATR (14)	1.18
RSI (14)	44.63
Beta	1.43
Rel Volume	0.84
Avg Volume	75.69K
Volume	63,650

Perf Week	-18.94%
Perf Month	15.95%
Perf Quarter	-16.27%
Perf Half Y	57.28%
Perf YTD	-20.76%
Perf Year	-71.38%
Perf 3Y	-93.80%
Perf 5Y	-99.37%
Perf 10Y	-99.87%
Recom	1.00
Target Price	25.50
Prev Close	9.88
Price	9.16
Change %	-7.24%

Affiliate • Advertise • API and Exports • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Stock quotes delayed by 1 minute. Futures and options delayed by 15 minutes.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)